| Hans-Günter Meyer-Thompson | Legal
USA. Controversy over Suboxone
In September, the controversy over buprenorphine took on another dimension when 35 states and the District sued drugmaker Indivior for violating antitrust laws. (The Washington Post, 24.10.2016)